NOVAVAX INC (NVAX)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-20 | Rodgers Richard J | director | M | 18,880 | — | — |
| 2026-06-20 | King Rachel K. | director | M | 18,880 | — | — |
| 2026-06-20 | DOUGLAS RICHARD | director | M | 18,880 | — | — |
| 2026-06-20 | MCGLYNN MARGARET G | director | M | 18,880 | — | — |
| 2026-06-20 | MOTT DAVID M | director | M | 18,880 | — | — |
| 2026-06-20 | Alton Gregg H | director | M | 18,880 | — | — |
| 2026-06-20 | Rodgers Richard J | director | M | 18,880 | — | — |
| 2026-06-20 | King Rachel K. | director | M | 18,880 | — | — |
| 2026-06-20 | DOUGLAS RICHARD | director | M | 18,880 | — | — |
| 2026-06-20 | MCGLYNN MARGARET G | director | M | 18,880 | — | — |
| 2026-06-20 | MOTT DAVID M | director | M | 18,880 | — | — |
| 2026-06-20 | Alton Gregg H | director | M | 18,880 | — | — |
| 2026-04-25 | Newton Charles W. | director | M | 9,520 | 0 | $0 |
| 2026-04-25 | Newton Charles W. | director | M | 9,520 | 0 | $0 |
| 2026-03-10 | Shiver John W. | director | M | 7,947 | 0 | $0 |
| 2026-03-10 | Shiver John W. | director | M | 7,947 | 0 | $0 |
| 2026-03-07 | Kelly James Patrick | officer | M | 12,223 | 0 | $0 |
| 2026-03-07 | Kelly James Patrick | officer | F | 5,904 | 9.98 | $58,922 |
| 2026-03-07 | Kelly James Patrick | officer | M | 12,223 | 0 | $0 |
| 2026-03-07 | Kelly James Patrick | officer | F | 5,904 | 9.98 | $58,922 |
| 2026-03-03 | Kelly James Patrick | officer | M | 43,167 | 0 | $0 |
| 2026-03-03 | Kelly James Patrick | officer | F | 20,850 | 9.49 | $197,867 |
| 2026-03-03 | Jacobs John C | director | M | 150,167 | 0 | $0 |
| 2026-03-03 | Jacobs John C | director | F | 69,288 | 9.49 | $657,543 |
| 2026-03-03 | O'Hara Elaine | officer | F | 22,429 | 9.49 | $212,851 |
| 2026-03-03 | O'Hara Elaine | officer | M | 56,334 | 0 | $0 |
| 2026-03-03 | Casey Mark J | officer | F | 11,378 | 9.49 | $107,977 |
| 2026-03-03 | Casey Mark J | officer | M | 37,500 | 0 | $0 |
| 2026-03-03 | Draghia-Akli Ruxandra | officer | M | 26,667 | 0 | $0 |
| 2026-03-03 | Draghia-Akli Ruxandra | officer | F | 11,313 | 9.49 | $107,360 |
| 2026-03-03 | Kelly James Patrick | officer | M | 43,167 | 0 | $0 |
| 2026-03-03 | Kelly James Patrick | officer | F | 20,850 | 9.49 | $197,867 |
| 2026-03-03 | Jacobs John C | director | M | 150,167 | 0 | $0 |
| 2026-03-03 | Jacobs John C | director | F | 69,288 | 9.49 | $657,543 |
| 2026-03-03 | O'Hara Elaine | officer | M | 56,334 | 0 | $0 |
| 2026-03-03 | O'Hara Elaine | officer | F | 22,429 | 9.49 | $212,851 |
| 2026-03-03 | Casey Mark J | officer | M | 37,500 | 0 | $0 |
| 2026-03-03 | Casey Mark J | officer | F | 11,378 | 9.49 | $107,977 |
| 2026-03-03 | Draghia-Akli Ruxandra | officer | M | 26,667 | 0 | $0 |
| 2026-03-03 | Draghia-Akli Ruxandra | officer | F | 11,313 | 9.49 | $107,360 |
| 2026-03-01 | Jacobs John C | director | F | 38,450 | 10.14 | $389,883 |
| 2026-03-01 | Jacobs John C | director | M | 83,333 | 0 | $0 |
| 2026-03-01 | Kelly James Patrick | officer | F | 28,366 | 10.14 | $287,631 |
| 2026-03-01 | Kelly James Patrick | officer | M | 58,666 | 0 | $0 |
| 2026-03-01 | O'Hara Elaine | officer | M | 40,000 | 0 | $0 |
| 2026-03-01 | O'Hara Elaine | officer | F | 5,375 | 10.14 | $54,503 |
| 2026-03-01 | O'Hara Elaine | officer | M | 19,600 | 0 | $0 |
| 2026-03-01 | O'Hara Elaine | officer | F | 10,969 | 10.14 | $111,226 |
| 2026-03-01 | Casey Mark J | officer | F | 1,214 | 10.14 | $12,310 |
| 2026-03-01 | Casey Mark J | officer | M | 4,000 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
7-day average 78 views/day vs 90-day median 55.